Search Results - "Tanamai, J."

Angiotensin II receptor blocker partially ameliorated intrarenal hypoxia in chronic kidney disease patients: a pre-/post-study by Manotham, K., Ongvilawan, B., Urusopone, P., Chetsurakarn, S., Tanamai, J., Limkuansuwan, P., Tungsanga, K., Eiam-Ong, S.

“…Chronic intrarenal hypoxia has been regarded as a pathogenic factor of progressive renal damage. However, the lack of available human data has impeded the…”
Get full text

Glutaraldehyde erythropoietin protects kidney in ischaemia/reperfusion injury without increasing red blood cell production by Chattong, S, Tanamai, J, Kiatsomchai, P, Nakatsu, M, Sereemaspun, A, Pimpha, N, Praditpornsilpa, K, Rojanathanes, R, Sethpakadee, A, Tungsanga, K, Eiam‐Ong, S, Manotham, K

“…Background and Purpose Recombinant human erythropoietin (rHuEPO) is currently the mainstay of renal anaemia treatment. Recently, rHuEPO has been shown to…”
Get full text